Guardant Health (GH) Enterprise Value (2017 - 2026)

Guardant Health has disclosed Enterprise Value across 10 years of filings, most recently posting -$1.1 billion for Q1 2026.

• Enterprise Value for Q1 2026 came in at -$1.1 billion, down 57.86% year-over-year; the trailing twelve-month figure through Mar 2026 was -$1.1 billion (down 57.86% YoY), and the FY2025 annual result was -$1.2 billion, down 43.05% from the prior year.
• Enterprise Value came in at -$1.1 billion for Q1 2026 at Guardant Health, up from -$1.2 billion in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of -$580.0 million in Q3 2025 to a low of -$1.2 billion in Q2 2023.
• The 5-year median for Enterprise Value is -$958.0 million (2022), against an average of -$951.8 million.
• Across the five-year window, Enterprise Value jumped 50.72% in 2022 and slumped 57.86% in 2026, its largest moves.
• Guardant Health's Enterprise Value stood at -$1.0 billion in 2022, then retreated by 15.57% to -$1.2 billion in 2023, then increased by 28.12% to -$840.0 million in 2024, then tumbled by 43.05% to -$1.2 billion in 2025, then grew by 8.23% to -$1.1 billion in 2026.
• The last three Enterprise Value figures came in at -$1.1 billion (Q1 2026), -$1.2 billion (Q4 2025), and -$580.0 million (Q3 2025), per Business Quant data.